Processing

Please wait...

Settings

Settings

Goto Application

1. WO2006101867 - TREATMENT OF INFLAMMATORY BOWEL DISEASE

Publication Number WO/2006/101867
Publication Date 28.09.2006
International Application No. PCT/US2006/009222
International Filing Date 14.03.2006
IPC
A61P 29/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
29Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (NSAIDs)
A61K 31/5575 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
557Eicosanoids, e.g. leukotrienes
5575having a cyclopentane ring, e.g. prostaglandin E2, prostaglandin F2-alpha
CPC
A61K 31/557
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
557Eicosanoids, e.g. leukotrienes ; or prostaglandins
A61K 31/5575
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
557Eicosanoids, e.g. leukotrienes ; or prostaglandins
5575having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
A61K 31/559
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
557Eicosanoids, e.g. leukotrienes ; or prostaglandins
559having heterocyclic rings containing hetero atoms other than oxygen
A61P 1/04
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
1Drugs for disorders of the alimentary tract or the digestive system
04for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
C07C 57/26
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
CACYCLIC OR CARBOCYCLIC COMPOUNDS
57Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
26containing rings other than six-membered aromatic rings
C07C 57/48
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
CACYCLIC OR CARBOCYCLIC COMPOUNDS
57Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
46containing six-membered aromatic rings and other rings, e.g. cyclohexylphenylacetic acid
48having unsaturation outside the aromatic rings
Applicants
  • ALLERGAN, INC. [US]/[US] (AllExceptUS)
  • DONDE, Yariv [US]/[US] (UsOnly)
  • NGUYEN, Jeremiah, H. [US]/[US] (UsOnly)
  • KEDZIE, Karen, M. [US]/[US] (UsOnly)
  • GIL, Daniel, W. [US]/[US] (UsOnly)
  • DONELLO, John, E. [US]/[US] (UsOnly)
  • IM, Wha-bin [US]/[US] (UsOnly)
Inventors
  • DONDE, Yariv
  • NGUYEN, Jeremiah, H.
  • KEDZIE, Karen, M.
  • GIL, Daniel, W.
  • DONELLO, John, E.
  • IM, Wha-bin
Agents
  • JOHNSON, Brent
Priority Data
11/084,45417.03.2005US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) TREATMENT OF INFLAMMATORY BOWEL DISEASE
(FR) TRAITEMENT DE MALADIE INTESTINALE INFLAMMATOIRE
Abstract
(EN)
Disclosed herein is a method comprising administering a compound to a mammal suffering from an inflammatory bowel disease for the treatment of said disease, said compound having a structure according to Formula I wherein X, Y, B, R2, R3, R4, R5, R6 and n have the meanings found herein.
(FR)
L'invention concerne une méthode consistant à administrer un composé à un mammifère atteint d'une maladie intestinale inflammatoire pour le traitement de ladite maladie, ledit composé présentant une structure conforme à la formule I, dans laquelle X, Y, B, R2, R3, R4, R5, R6 et n ont les significations décrites dans l'invention.
Latest bibliographic data on file with the International Bureau